MNKD MannKind Corporation - Common Stock
$4,26
Preço · Ago 19, 2026
Fundamentais a partir de Ago 5, 2026
Intervalo 52 Semanas
$2–$7
47% of range
Classificação do Analista
BUY
14 analysts
Preço-Alvo
$8
+87% upside
P/E (TTM)
212.9
ROE
-11.1%
Margem de Lucro Líquido
1.7%
Sobre MannKind Corporation - Common Stock Visão geral da empresa da Wikipedia
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
Ler mais
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.
MannKind Corporation was named after its founder, Alfred E. Mann.
History
Founded in February 1991, the company's present form is a result of a 2003 merger of three companies owned by Alfred E. Mann: Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing an allergy vaccine technology. Pharmaceutical Discovery was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).
The FDA approved Afrezza on June 27, 2014.
On August 11, 2014 MannKind entered into an exclusive global licensing agreement with Sanofi for Afrezza sales. Under the agreement, MannKind received $150 million cash from Sanofi, in exchange for sharing profits and losses of sales of Afrezza, with 65% for Sanofi and 35% for MannKind. On January 5, 2016, MannKind Corporation announced the termination of the license and collaboration agreement with Sanofi. By December 2017, the company had lost 11% of its trading volume due to the poor sales.
In March 2020, the company announced it was working with fellow pharmaceutical company Immix Biopharma to try to develop an inhalable treatment for acute respiratory distress syndrome, a lung disease.
Products and product candidates
The firm has developed Afrezza a rapid-acting insulin peaking 12 to 15 minutes after inhalation and exiting the body within 2–3 hours. The inhalation technology uses a miniature, breath-powered inhaler in combination with single-use cartridges containing pre-metered doses. Initial pharmacokinetic studies were followed by studies of safety and efficiency involving Technosphere formulations of different therapeutic proteins.
Leadership
Mann was chief executive officer until January 12, 2015 when Hakan Edstrom became CEO and Mann transitioned to executive chairman.
In November 2015, Hakan Edstrom stepped down as CEO and president. Company founder Alfred Mann stepped in as interim CEO on November 19, 2015. In 2016, Matthew Pfeffer was appointed CEO of MannKind, and served as both CEO and CFO. In May 2017, Michael Castagna was named CEO of the company.
Facilities
MannKind has a large corporate office in Westlake Village, California. The Afrezza manufacturing facility is in Danbury, Connecticut. In 2022, the company moved its official headquarters to Danbury.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
MNKD Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$4.26
Capitalização de Mercado
$1.31B
P/E (TTM)
212.9
EPS (TTM)
$0.02
Receita (TTM)
$349M
Rendimento div.
—
ROE
-11.1%
Dívida/Capital
—
Intervalo 52 Semanas
$2 – $7
MNKD Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$349M
2016-12-31
→
2025-12-31
EPS
$0.02
2016-12-31
→
2025-12-31
Fluxo de caixa livre
$14M
2018-12-31
→
2025-12-31
Margens
1.7%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
MNKD
Mediana de Pares
P/E (TTM)
212.9
—
P/S (TTM)
3.8
10.7
P/B
-25.7
5.2
Price / FCF (Preço / FCF)
95.7
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
MNKD
Mediana de Pares
Operating Margin (Margem Operacional)
11.1%
—
Net Profit Margin (Margem de Lucro Líquido)
1.7%
-140.3%
ROA
0.99%
-44.7%
ROE
-11.1%
-51.5%
ROIC
-316.9%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
MNKD
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
1.7
9.5
Quick Ratio (Índice de Liquidez Seca)
1.2
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
MNKD
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
22.2%
—
Revenue CAGR 3Y (CAGR Receita 3A)
51.8%
—
Revenue CAGR 5Y (CAGR Receita 5A)
39.9%
—
EPS YoY
-80.0%
—
Net Income YoY (Lucro Líquido Ano a Ano)
-78.8%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
MNKD
Mediana de Pares
MNKD Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
14 analistas
- Compra forte 4 28,6%
- Compra 8 57,1%
- Manter 2 14,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
8 analistas · 2026-08-17
Mediana
$7.50
← Abaixo de todos os alvos
$4.26
Mín
$4.75
Máx
$13.00
Alvo mediano
$7.50
+76,2%
Alvo médio
$7.97
+87,2%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-0.03%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.06 | $-0.00 | -0.06% |
| 31 de Março de 2026 | $-0.05 | $-0.00 | -0.05% |
| 31 de Dezembro de 2025 | $-0.05 | $0.01 | -0.06% |
| 30 de Setembro de 2025 | $0.07 | $0.02 | 0.05% |
| 30 de Junho de 2025 | $0.00 | $0.05 | -0.05% |
| 31 de Março de 2025 | $0.04 | $0.04 | -0.00% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | — |
| GLUE | $1.03B | — | 63.5% | -31.2% | -15.4% | — |
| MGTX | $645M | -5.6 | 144.6% | -140.3% | 8062.2% | — |
| CRVS | $575M | -14.5 | — | — | -21.6% | — |
| REPL | $633M | -2.3 | — | — | -146.2% | — |
| VOR | $506M | -0.2 | — | — | 83.4% | — |
| SANA | $1.09B | -4.2 | — | — | -172.3% | — |
| SVRA | $1.23B | -11.4 | — | — | -73.4% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Cost of Revenue | $27M | $17M | $21M | $16M | $17M | $15M | $20M | $19M | $17M | $17M | $65M | · | |
| SG&A Expense | $144M | $94M | $94M | $91M | $32M | $25M | $75M | $80M | $75M | $47M | $41M | $79M | |
| Operating Expenses | $88M | $77M | $63M | $57M | $39M | $25M | $108M | $104M | $120M | $107M | $345M | $180M | |
| Operating Income | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-108M | $67M | $-345M | $-180M | |
| Interest Expense | · | · | $15M | $15M | $15M | · | · | · | · | · | $24M | $20M | |
| Interest Income | $8M | $13M | $6M | $3M | $112.0K | $167.0K | $997.0K | $501.0K | $293.0K | $85.0K | $18.0K | $9.0K | |
| Other Non-op | $-1M | $32.0K | $122.0K | $-102.0K | $-239.0K | $23.0K | $-926.0K | $-437.0K | $13.0K | $-597.0K | $1M | $2M | |
| Pretax Income | $1M | $31M | $-10M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Income Tax | $-4M | $3M | $2M | $0 | $0 | $-218.0K | $0 | $240.0K | $51.0K | $0 | $0 | $0 | |
| Net Income | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| EPS (Basic) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.37 | $-4.54 | $-2.57 | |
| EPS (Diluted) | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 | $-0.26 | · | $-0.60 | $-1.13 | $1.36 | $-4.54 | $-2.57 | |
| Shares (Basic) | 305,639,000 | 274,415,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,053,000 | 81,233,000 | 77,045,000 | |
| Shares (Diluted) | 314,112,000 | 283,844,000 | 267,014,000 | 257,092,000 | 249,244,000 | 222,585,000 | · | 144,136,000 | 104,245,000 | 92,085,000 | 81,233,000 | 77,045,000 | |
| EBITDA | $39M | $73M | $9M | $-64M | $-47M | $-48M | $-45M | $-77M | $-106M | · | $-334M | $-170M |
Balanço Patrimonial 28
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $75M | $46M | $238M | $70M | $124M | $67M | $30M | $71M | $44M | $23M | $59M | $121M | |
| Short-term Investments | $96M | $151M | $57M | $101M | $80M | $0 | $20M | · | · | · | · | · | |
| Receivables | $38M | $12M | $15M | $17M | $5M | $4M | $4M | $4M | $3M | $302.0K | $23.0K | $50M | |
| Inventory | $35M | $28M | $29M | $22M | $7M | $5M | $4M | $4M | $3M | $2M | · | $10M | |
| Prepaid Expense | $47M | $31M | $35M | $25M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $20M | |
| Current Assets | $292M | $268M | $373M | $235M | $219M | $79M | $61M | $82M | $57M | $77M | $77M | $201M | |
| PP&E (Net) | $82M | $85M | $84M | $45M | $37M | $26M | $27M | $26M | $27M | $29M | $49M | $192M | |
| PP&E (Gross) | $196M | $192M | $186M | $144M | $134M | $123M | $122M | $126M | $128M | $129M | $168M | $310M | |
| Accum. Depreciation | $114M | $107M | $102M | $99M | $98M | $97M | $95M | $100M | $101M | $100M | $120M | $118M | |
| Goodwill | $68M | $2M | $2M | $2M | · | · | · | · | · | · | · | · | |
| Intangibles | $5M | $5M | $1M | $1M | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $20M | $27M | $7M | $10M | $8M | $3M | $6M | $249.0K | $437.0K | $648.0K | $1M | $848.0K | |
| Total Assets | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Accounts Payable | $9M | $7M | $10M | $11M | $7M | $6M | $5M | $5M | $7M | $3M | $16M | $7M | |
| Accrued Liabilities | $65M | $40M | $42M | $36M | $27M | $20M | $16M | $15M | $12M | $8M | $8M | $26M | |
| Short-term Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Current Liabilities | $171M | $82M | $104M | $67M | $48M | $74M | $66M | $75M | $88M | $92M | $268M | $403M | |
| Capital Leases | $11M | $12M | $4M | $5M | $1M | $1M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $5M | · | · | · | · | · | $15M | $12M | |
| Total Liabilities | $843M | $473M | $721M | $546M | $531M | $289M | $284M | $283M | $299M | $291M | $477M | $468M | |
| Long-term Debt | $355M | $36M | $269M | $273M | $281M | $122M | $119M | $102M | $157M | · | · | · | |
| Total Debt | · | · | · | · | · | · | $5M | · | · | · | · | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $4M | $4M | |
| Retained Earnings | $-3.20B | $-3.20B | $-3.23B | $-3.22B | $-3.13B | $-3.05B | $-2.99B | $-2.94B | $-2.85B | $-2.74B | $-2.86B | $-2.49B | |
| AOCI | $115.0K | $1M | · | · | · | · | $-19.0K | $-19.0K | $-18.0K | $-24.0K | $-20.0K | $-14.0K | |
| Stockholders' Equity | $-51M | $-79M | $-246M | $-251M | $-209M | $-180M | $-191M | $-175M | $-215M | $-184M | $-350M | $-74M | |
| Liabilities + Equity | $792M | $394M | $475M | $295M | $321M | $109M | $94M | $108M | $85M | $107M | $126M | $394M | |
| Shares Outstanding | 307,832,587 | 302,959,782 | 270,034,495 | 263,793,305 | 251,477,562 | 242,117,089 | 211,787,573 | 187,029,967 | 119,053,414 | 95,680,831 | 85,734,188 | 406,059,089 |
Fluxo de Caixa 18
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $7M | $5M | $3M | $2M | $2M | $972.0K | $3M | $2M | $2M | $11M | $10M | |
| Stock-based Comp | $24M | $21M | $18M | $13M | $12M | $7M | $6M | $7M | $5M | $5M | $9M | $49M | |
| Deferred Tax | $-19M | $4M | $7M | $-10M | $-20M | $-5M | $-5M | $-11M | $-260M | $48M | $-80M | $-66M | |
| Amort. of Intangibles | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $6M | $2M | |
| Other Non-cash | · | · | · | · | · | · | · | · | $306M | · | $291M | $144M | |
| Operating Cash Flow | $18M | $43M | $34M | $-81M | $-62M | $-28M | $-88M | $-38M | $-65M | $-78M | $-57M | $4M | |
| CapEx | $5M | $10M | $42M | $8M | $11M | $801.0K | $3M | $354.0K | · | $1M | $10M | $24M | |
| Investing Cash Flow | $-305M | $-97M | $-2M | $5M | $-152M | $15M | $-23M | $-234.0K | $17M | $-1M | · | · | |
| Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | $5M | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | · | $564.0K | $893.0K | $28M | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $564.0K | · | $28M | · | |
| Financing Cash Flow | $315M | $-137M | $137M | $21M | $270M | $50M | $70M | $61M | $74M | $43M | · | · | |
| Net Change in Cash | $29M | $-191M | $169M | $-54M | $57M | $37M | $-41M | $23M | $25M | $-36M | $-62M | $50M | |
| Taxes Paid | $2M | $4M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $14M | $33M | $-8M | $-88M | $-73M | $-29M | $-91M | $-38M | · | · | $-68M | $-20M | |
| Levered FCF | · | · | $-26M | $-98M | · | · | · | · | · | · | $-92M | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -921.1% | · | · | · | |
| Net Margin | 1.7% | 9.7% | -6.0% | -87.6% | -107.3% | -87.9% | -82.3% | -312.2% | -999.0% | · | · | · | |
| Pretax Margin | 0.40% | 10.7% | -5.2% | -87.6% | -107.3% | -88.2% | -82.3% | -311.3% | -998.6% | · | · | · | |
| EBITDA Margin | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% | -73.6% | -70.8% | -274.9% | -905.8% | · | · | · | |
| ROA | 0.99% | 6.3% | -3.1% | -28.4% | -37.7% | -56.6% | -51.5% | -90.5% | -122.4% | · | -141.5% | -60.8% | |
| ROE | -11.1% | -19.1% | 4.8% | 35.8% | 41.1% | 31.2% | 27.7% | 45.7% | 58.9% | · | 173.8% | 379.7% | |
| ROIC | -316.9% | -83.2% | -4.1% | 25.6% | 22.5% | 26.5% | 24.0% | 43.9% | 50.4% | · | 98.4% | · |
Liquidez e Solvência 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 | 1.1 | 0.9 | 1.1 | 0.7 | · | 0.3 | 0.5 | |
| Quick Ratio | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 | 1.0 | 0.8 | 1.0 | 0.5 | · | 0.2 | 0.4 | |
| Debt / Equity | · | · | · | · | · | · | -0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | 0.6 | -6.7 | · | · | · | · | · | · | -14.3 | -8.8 |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.6 | 0.3 | 0.1 | · | 0.0 | · | |
| Inventory Turnover | 0.8 | 0.6 | 0.8 | 1.1 | 2.8 | 3.3 | 5.2 | 6.2 | 6.9 | · | · | · | |
| Receivables Turnover | 13.9 | 21.4 | 12.6 | 9.3 | 16.4 | 16.9 | 16.7 | 8.2 | 7.6 | · | 0.0 | · |
Taxas de Crescimento 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 22.2% | 43.5% | 99.4% | 32.2% | 15.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 51.8% | 55.8% | 45.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 39.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -80.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -78.8% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $349M | $286M | $199M | $100M | $75M | $65M | $63M | $28M | $12M | $175M | $0 | $0 | |
| Net Income TTM | $6M | $28M | $-12M | $-87M | $-81M | $-57M | $-52M | $-87M | $-117M | $126M | $-368M | $-198M | |
| Market Cap | $1.75B | $1.95B | $983M | $1.39B | $1.10B | $758M | $273M | $198M | $276M | · | $3.11B | $10.60B | |
| Enterprise Value | · | · | · | · | · | · | $228M | · | · | · | · | · | |
| P/E | 283.5 | 64.3 | -91.0 | -15.5 | -13.7 | -12.0 | -2.0 | -1.8 | -2.1 | 2.4 | -1.6 | -10.2 | |
| P/S | 5.0 | 6.8 | 4.9 | 13.9 | 14.6 | 11.6 | 4.3 | 7.1 | 23.5 | · | · | · | |
| P/B | -34.2 | -24.7 | -4.0 | -5.5 | -5.2 | -4.2 | -1.4 | -1.1 | -1.3 | · | -8.9 | -143.7 | |
| P / Cash Flow | 95.6 | 45.8 | 28.8 | -17.2 | -17.8 | -26.9 | -3.1 | -5.3 | -4.3 | · | -54.3 | 2593.8 | |
| P / FCF | 127.5 | 59.4 | -117.8 | -15.7 | -15.0 | -26.2 | -3.0 | -5.2 | · | · | -46.0 | -529.6 | |
| EV / EBITDA | · | · | · | · | · | · | -5.1 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | -2.5 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | 3.6 | · | · | · | · | · | |
| Earnings Yield | 0.35% | 1.6% | -1.1% | -6.5% | -7.3% | -8.3% | -48.8% | -56.6% | -48.7% | 42.5% | -62.6% | -9.8% |
Demonstração de Resultados 16
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109M | $90M | $112M | $82M | $77M | $78M | $77M | $70M | $72M | $66M | $58M | $51M | $49M | $41M | $36M | $33M | |
| Cost of Revenue | $14M | $8M | $14M | $4M | $5M | $4M | $5M | $3M | $6M | $4M | $6M | $4M | $5M | $6M | $4M | $5M | |
| SG&A Expense | $58M | $54M | $58M | $29M | $32M | $25M | $24M | $24M | $24M | $22M | $61M | $11M | $12M | $11M | $64M | $9M | |
| Operating Expenses | $30M | $92M | $-103M | $63M | $21M | $56M | $-86M | $57M | $56M | $50M | $18M | $14M | $14M | $16M | $16M | $17M | |
| Operating Income | $-350.0K | $-2M | $-8M | $19M | $5M | $22M | $26M | $13M | $17M | $17M | $8M | $5M | $2M | $-6M | $-13M | $-10M | |
| Interest Expense | · | · | · | · | · | · | · | · | $6M | $3M | · | $3M | $7M | $3M | · | $3M | |
| Interest Income | $1M | $1M | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $957.0K | $663.0K | |
| Other Non-op | $-5M | $-3M | $23M | $-11M | $-4M | $-9M | $24M | $110.0K | $-18M | $-6M | $-164.0K | $318.0K | $-143.0K | $111.0K | $105.0K | $-207.0K | |
| Pretax Income | $-19M | $-16M | $-21M | $8M | $940.0K | $14M | $8M | $13M | $-2M | $11M | $3M | $2M | $-5M | $-10M | $-18M | $-14M | |
| Income Tax | $-106.0K | $253.0K | $-5M | $-204.0K | $272.0K | $459.0K | $1M | $1M | $323.0K | $264.0K | $2M | $0 | $0 | $0 | · | $0 | |
| Net Income | $-19M | $-17M | $-16M | $8M | $668.0K | $13M | $7M | $12M | $-2M | $11M | $1M | $2M | $-5M | $-10M | $-18M | $-14M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.05 | $0.03 | $0.00 | $0.04 | $0.03 | $0.04 | $-0.01 | $0.04 | $0.01 | $0.01 | $-0.02 | $-0.04 | $-0.07 | $-0.06 | |
| Shares (Basic) | 309,191,000 | 308,267,000 | -609,602,000 | 306,806,000 | 304,954,000 | 303,481,000 | -543,995,000 | 274,998,000 | 273,056,000 | 270,356,000 | -531,313,000 | 268,732,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| Shares (Diluted) | 309,191,000 | 308,267,000 | -629,907,000 | 311,638,000 | 311,484,000 | 320,897,000 | -598,638,000 | 284,693,000 | 273,056,000 | 324,733,000 | -586,351,000 | 323,770,000 | 265,626,000 | 263,969,000 | -507,739,000 | 259,300,000 | |
| EBITDA | · | $-2M | · | $19M | $5M | $22M | · | $13M | $17M | $17M | · | $5M | $2M | $-6M | · | $-10M |
Balanço Patrimonial 25
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $53M | $53M | $75M | $127M | $57M | $47M | $46M | $62M | $97M | $193M | · | $83M | $86M | $86M | · | $54M | |
| Short-term Investments | $58M | $81M | $96M | $133M | $122M | $134M | $151M | $189M | $151M | $107M | · | $58M | $58M | $80M | · | $111M | |
| Receivables | $43M | $28M | $38M | $17M | $27M | $29M | $12M | $18M | $23M | $20M | · | $22M | $28M | $20M | · | $23M | |
| Inventory | $44M | $49M | $35M | $27M | $28M | $29M | $28M | $27M | $25M | $26M | · | $27M | $25M | $22M | · | $18M | |
| Prepaid Expense | $47M | $40M | $47M | $54M | $44M | $34M | $31M | $31M | $30M | $36M | · | $36M | $33M | $15M | · | $12M | |
| Current Assets | $246M | $251M | $292M | $359M | $279M | $274M | $268M | $328M | $326M | $383M | · | $226M | $230M | $223M | · | $218M | |
| PP&E (Net) | $85M | $83M | $82M | $83M | $83M | $84M | $85M | $85M | $85M | $84M | · | $80M | $70M | $55M | · | $41M | |
| PP&E (Gross) | $203M | $198M | $196M | $195M | $194M | $192M | $192M | $192M | $190M | $186M | · | $182M | $170M | $154M | · | $140M | |
| Accum. Depreciation | $118M | $116M | $114M | $113M | $111M | $109M | $107M | $107M | $105M | $103M | · | $101M | $100M | $100M | · | $99M | |
| Goodwill | $68M | $68M | $68M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Other Non-current Assets | $17M | $22M | $20M | $19M | $20M | $28M | $27M | $26M | $16M | $7M | · | $8M | $8M | $16M | · | $17M | |
| Total Assets | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Accounts Payable | $11M | $16M | $9M | $7M | $10M | $5M | $7M | $6M | $10M | $7M | · | $17M | $17M | $14M | · | $10M | |
| Accrued Liabilities | $61M | $59M | $65M | $31M | $31M | $40M | $40M | $37M | $41M | $42M | · | $32M | $37M | $33M | · | $30M | |
| Current Liabilities | $143M | $135M | $171M | $109M | $112M | $116M | $82M | $72M | $80M | $100M | · | $96M | $97M | $82M | · | $60M | |
| Capital Leases | $10M | $10M | $11M | $10M | $11M | $11M | $12M | $12M | $3M | $4M | · | $4M | $5M | $5M | · | $6M | |
| Total Liabilities | $800M | $804M | $843M | $539M | $467M | $469M | $473M | $674M | $670M | $711M | · | $572M | $574M | $554M | · | $532M | |
| Long-term Debt | $319M | $319M | $355M | $110M | $36M | $36M | $36M | $228M | $228M | $264M | · | $273M | $274M | $274M | · | $273M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $-3.23B | $-3.21B | $-3.20B | $-3.18B | $-3.19B | $-3.19B | $-3.20B | $-3.21B | $-3.22B | $-3.22B | · | $-3.23B | $-3.23B | $-3.23B | · | $-3.20B | |
| AOCI | $-19.0K | $-4.0K | $115.0K | $137.0K | $1M | $1M | $1M | $588.0K | · | · | · | $443.0K | $443.0K | · | · | $-1M | |
| Stockholders' Equity | $-67M | $-59M | $-51M | $-45M | $-55M | $-59M | $-79M | $-210M | $-226M | $-230M | $-246M | $-252M | $-260M | $-255M | $-251M | $-238M | |
| Liabilities + Equity | $732M | $744M | $792M | $495M | $412M | $410M | $394M | $464M | $444M | $481M | · | $320M | $313M | $298M | · | $294M | |
| Shares Outstanding | 309,911,682 | 308,907,331 | 307,832,587 | 307,027,189 | 306,332,133 | 303,918,969 | 302,959,782 | 275,775,038 | 274,467,247 | 270,801,781 | · | 269,543,539 | 268,235,145 | 264,278,760 | · | 263,156,165 |
Fluxo de Caixa 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $6M | $6M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $-427.0K | |
| Stock-based Comp | $10M | $6M | $7M | $4M | $8M | $5M | $6M | $5M | $6M | $4M | $4M | $5M | $6M | $4M | $3M | $4M | |
| Amort. of Intangibles | $4M | $4M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-18M | $-5M | $-8M | $24M | $9M | $-6M | $23M | $9M | $4M | $7M | $22M | $9M | $3M | $1M | $-2M | $-28M | |
| CapEx | $5M | $2M | $2M | $1M | $1M | $330.0K | $3M | $1M | $3M | $2M | $6M | $11M | $17M | $8M | $5M | $271.0K | |
| Investing Cash Flow | $18M | $19M | $-292M | $-25M | $6M | $6M | $48M | $-41M | $-55M | $-48M | $-8M | $-12M | $4M | $14M | $15M | $27M | |
| Financing Cash Flow | $559.0K | $-35M | $247M | $72M | $-6M | $1M | $-87M | $-2M | $-45M | $-3M | $142M | $-283.0K | $-6M | $1M | $3M | $20M | |
| Net Change in Cash | $97.0K | $-22M | $-53M | $70M | $10M | $975.0K | $-16M | $-34M | $-96M | $-45M | $155M | $-3M | $315.0K | $16M | $15M | $19M | |
| Taxes Paid | $753.0K | $63.0K | $549.0K | $80.0K | $869.0K | $207.0K | $2M | $236.0K | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-7M | · | · | · | $-7M | · | · | · | $4M | · | · | · | $-7M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $2M | · | · | · | $-10M | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| Net Margin | · | -18.4% | · | 9.7% | 0.87% | 16.8% | · | 16.5% | -2.8% | 16.0% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| Pretax Margin | · | -18.1% | · | 9.5% | 1.2% | 17.4% | · | 18.4% | -2.3% | 16.4% | · | 3.4% | -10.8% | -24.1% | · | -44.0% | |
| EBITDA Margin | · | -1.8% | · | 23.0% | 6.9% | 28.4% | · | 18.2% | 22.9% | 25.2% | · | 9.9% | 3.5% | -14.8% | · | -29.3% | |
| ROA | · | -2.9% | · | 1.7% | 0.16% | 2.9% | · | 2.9% | -0.53% | 2.7% | · | 0.56% | -1.8% | -3.2% | · | -5.4% | |
| ROE | · | 28.2% | · | -6.3% | -0.48% | -9.1% | · | -5.0% | 0.83% | -4.4% | · | -0.70% | 2.1% | 4.0% | · | 6.8% | |
| ROIC | · | 2.9% | · | -43.5% | -6.8% | -36.8% | · | -5.5% | -8.8% | -7.1% | · | -2.0% | -0.66% | 2.4% | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 3.3 | 2.5 | 2.4 | · | 4.5 | 4.1 | 3.8 | · | 2.3 | 2.4 | 2.7 | · | 3.7 | |
| Quick Ratio | · | 1.2 | · | 2.5 | 1.8 | 1.8 | · | 3.7 | 3.4 | 3.2 | · | 1.7 | 1.8 | 2.3 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 2.7 | 6.5 | · | 1.8 | 0.3 | -2.5 | · | · |
Eficiência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.4 | · | 0.4 | |
| Receivables Turnover | 3.1 | 3.2 | · | 4.6 | 3.0 | 3.2 | · | 3.5 | 2.8 | 3.3 | · | 2.3 | 2.3 | 2.8 | · | 2.0 |
Avaliação (TTM) 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $358M | $327M | · | $307M | $297M | $287M | · | $260M | $239M | $207M | · | $173M | $141M | $104M | · | $86M | |
| Net Income TTM | $-27M | $5M | · | $33M | $23M | $33M | · | $22M | $5M | $-3M | · | $-28M | $-59M | $-79M | · | $-74M | |
| Market Cap | $1.32B | $757M | · | $1.65B | $1.15B | $1.53B | · | $1.73B | $1.43B | $1.23B | · | $1.11B | $1.09B | $1.08B | · | $813M | |
| P/E | -53.2 | 122.5 | · | 48.8 | 53.4 | 45.7 | · | 78.6 | 261.0 | -453.0 | · | -37.5 | -17.7 | -13.2 | · | -10.7 | |
| P/S | 3.7 | 2.3 | · | 5.4 | 3.9 | 5.3 | · | 6.7 | 6.0 | 5.9 | · | 6.4 | 7.7 | 10.4 | · | 9.5 | |
| P/B | -19.6 | -12.8 | · | -37.0 | -20.8 | -26.1 | · | -8.3 | -6.3 | -5.3 | · | -4.4 | -4.2 | -4.2 | · | -3.4 | |
| P / Cash Flow | · | -141.1 | · | · | · | -239.7 | · | · | · | 183.0 | · | · | · | 937.3 | · | · | |
| P / FCF | · | -104.5 | · | · | · | -227.9 | · | · | · | 285.6 | · | · | · | -151.4 | · | · | |
| Earnings Yield | -1.9% | 0.82% | · | 2.1% | 1.9% | 2.2% | · | 1.3% | 0.38% | -0.22% | · | -2.7% | -5.7% | -7.6% | · | -9.4% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $349M | $286M | $199M | $100M | $75M |
| Margem Operacional % | 11.1% | 25.4% | 4.4% | -64.3% | -62.3% |
| Lucro líquido | $6M | $28M | $-12M | $-87M | $-81M |
| EPS Diluído | $0.02 | $0.10 | $-0.04 | $-0.34 | $-0.32 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.7 | 3.3 | 3.6 | 3.5 | 4.5 |
| Índice de Liquidez Seca | 1.2 | 2.6 | 3.0 | 2.8 | 4.3 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $14M | $33M | $-8M | $-88M | $-73M |
Últimas notícias Notícias recentes mencionando esta empresa
- Wells Fargo Calls MannKind Corporation (MNKD)’s Commercial Potential a “Show-Me Story”
- MannKind (MNKD) Advances Clinical Trials for Inhaled IPF Therapy
- H.C. Wainwright e Wells Fargo elevam as metas de preço da MannKind (MNKD)
- A MannKind Corporation (MNKD) é uma das ações penny populares na Robinhood para comprar?
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 271 declarantes · $560.6M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 55 (+12 vs trimestre anterior) | 37 (-11 vs trimestre anterior) | 93 (+10 vs trimestre anterior) | 61 (-8 vs trimestre anterior) | +24.2M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $76.680.000 | 18.000.000 | 13,68% | Ações |
| STATE STREET CORP | $68.901.423 | 16.174.043 | 12,29% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $56.101.610 | 13.169.392 | 10,01% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $29.027.881 | 6.812.460 | 5,18% | Ações |
| Frazier Life Sciences Management, L.P. | $28.116.000 | 6.600.000 | 5,01% | Ações |
| Deep Track Capital, LP | $25.560.000 | 6.000.000 | 4,56% | Ações |
| WELLINGTON MANAGEMENT GROUP LLP | $23.099.232 | 5.422.355 | 4,12% | Ações |
| 180 WEALTH ADVISORS, LLC | $21.126.835 | 4.959.351 | 3,77% | Ações |
| FMR LLC | $17.455.563 | 4.097.550 | 3,11% | Ações |
| TSP Capital Management Group, LLC | $16.923.596 | 3.972.675 | 3,02% | Ações |
| BRAIDWELL LP | $14.732.908 | 3.458.429 | 2,63% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.789.240 | 3.002.169 | 2,28% | Ações |
| VANGUARD GROUP INC | $11.888.249 | 2.096.693 | 2,12% | Ações |
| TWO SIGMA INVESTMENTS, LP | $11.475.213 | 2.693.712 | 2,05% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $11.070.577 | 2.598.727 | 1,97% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $9.358.279 | 2.196.779 | 1,67% | Ações |
| BANK OF AMERICA CORP /DE/ | $8.689.749 | 2.039.847 | 1,55% | Ações |
| GOLDMAN SACHS GROUP INC | $6.332.618 | 1.486.530 | 1,13% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.030.221 | 1.180.803 | 0,90% | Ações |
| BlackRock, Inc. | $4.766.748 | 1.118.955 | 0,85% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $4.486.321 | 1.053.127 | 0,80% | Ações |
| Caption Management, LLC | $4.260.000 | 1.000.000 | 0,76% | Opção de venda |
| J. Goldman & Co LP | $3.478.669 | 816.589 | 0,62% | Ações |
| WELLS FARGO & COMPANY/MN | $3.473.987 | 815.490 | 0,62% | Ações |
| SCOPIA CAPITAL MANAGEMENT LP | $2.960.534 | 694.961 | 0,53% | Ações |
| Balyasny Asset Management L.P. | $2.914.296 | 684.107 | 0,52% | Ações |
| TWO SIGMA ADVISERS, LP | $2.897.166 | 510.964 | 0,52% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $2.771.407 | 650.565 | 0,49% | Ações |
| Swiss National Bank | $2.502.324 | 587.400 | 0,45% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $2.177.052 | 511.045 | 0,39% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.106.540 | 494.493 | 0,38% | Ações |
| 1492 Capital Management LLC | $2.052.136 | 481.722 | 0,37% | Ações |
| Mariner, LLC | $2.020.189 | 474.236 | 0,36% | Ações |
| MILLENNIUM MANAGEMENT LLC | $1.836.597 | 431.126 | 0,33% | Ações |
| Schonfeld Strategic Advisors LLC | $1.774.216 | 416.483 | 0,32% | Ações |
| Squarepoint Ops LLC | $1.759.644 | 413.062 | 0,31% | Ações |
| Jefferies Financial Group Inc. | $1.694.202 | 397.700 | 0,30% | Ações |
| ExodusPoint Capital Management, LP | $1.666.261 | 391.141 | 0,30% | Ações |
| JANE STREET GROUP, LLC | $1.658.418 | 389.300 | 0,30% | Opção de compra |
| Man Group plc | $1.624.023 | 381.226 | 0,29% | Ações |
| RHUMBLINE ADVISERS | $1.604.647 | 376.681 | 0,29% | Ações |
| IEQ CAPITAL, LLC | $1.544.607 | 362.584 | 0,28% | Ações |
| CITIGROUP INC | $1.499.243 | 351.935 | 0,27% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.423.692 | 334.200 | 0,25% | Opção de venda |
| Bank of New York Mellon Corp | $1.422.222 | 333.855 | 0,25% | Ações |
| Caption Management, LLC | $1.414.231 | 331.979 | 0,25% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1.359.221 | 319.066 | 0,24% | Ações |
| ALPS ADVISORS INC | $1.330.615 | 312.351 | 0,24% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.216.230 | 285.500 | 0,22% | Opção de compra |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.029.075 | 241.567 | 0,18% | Ações |
| BARCLAYS PLC | $1.029.062 | 241.564 | 0,18% | Ações |
| Rafferty Asset Management, LLC | $1.008.640 | 236.770 | 0,18% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $1.002.715 | 235.379 | 0,18% | Ações |
| Aaron Wealth Advisors LLC | $1.000.878 | 234.948 | 0,18% | Ações |
| HSBC HOLDINGS PLC | $998.560 | 230.881 | 0,18% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $930.294 | 379.712 | 0,17% | Ações |
| CITADEL ADVISORS LLC | $928.680 | 218.000 | 0,17% | Opção de compra |
| CITADEL ADVISORS LLC | $898.860 | 211.000 | 0,16% | Opção de venda |
| Bruce & Co., Inc. | $831.011 | 195.073 | 0,15% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $775.060 | 181.939 | 0,14% | Ações |
| MetLife Investment Management, LLC | $766.442 | 179.916 | 0,14% | Ações |
| FRANKLIN RESOURCES INC | $755.021 | 177.235 | 0,13% | Ações |
| Stonepine Capital Management, LLC | $750.000 | 250.000 | 0,13% | Opção de compra |
| UBS Group AG | $715.978 | 168.070 | 0,13% | Ações |
| ALLIANCEBERNSTEIN L.P. | $693.375 | 283.010 | 0,12% | Ações |
| MORGAN STANLEY | $651.282 | 152.883 | 0,12% | Ações |
| TUDOR INVESTMENT CORP ET AL | $640.657 | 150.389 | 0,11% | Ações |
| RAYMOND JAMES FINANCIAL INC | $632.009 | 148.359 | 0,11% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $613.437 | 171.372 | 0,11% | Ações |
| Jain Global LLC | $604.673 | 141.942 | 0,11% | Ações |
| KING LUTHER CAPITAL MANAGEMENT CORP | $590.457 | 138.605 | 0,11% | Ações |
| Susquehanna Portfolio Strategies, LLC | $574.538 | 134.868 | 0,10% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $570.354 | 133.886 | 0,10% | Ações |
| MERCER GLOBAL ADVISORS INC /ADV | $557.723 | 130.921 | 0,10% | Ações |
| PROFUND ADVISORS LLC | $517.726 | 121.532 | 0,09% | Ações |
| Invesco Ltd. | $512.389 | 120.279 | 0,09% | Ações |
| Vanguard Global Advisers, LLC | $509.833 | 119.679 | 0,09% | Ações |
| KLP KAPITALFORVALTNING AS | $491.604 | 115.400 | 0,09% | Ações |
| Gotham Asset Management, LLC | $452.463 | 106.212 | 0,08% | Ações |
| State of New Jersey Common Pension Fund D | $403.171 | 94.641 | 0,07% | Ações |
| State of Wyoming | $403.149 | 94.636 | 0,07% | Ações |
| Police & Firemen's Retirement System of New Jersey | $386.834 | 90.806 | 0,07% | Ações |
| Amundi | $374.310 | 87.866 | 0,07% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $373.478 | 87.671 | 0,07% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $359.966 | 84.499 | 0,06% | Ações |
| ARIZONA STATE RETIREMENT SYSTEM | $344.050 | 80.763 | 0,06% | Ações |
| Mitsubishi UFJ Asset Management Co., Ltd. | $338.155 | 79.379 | 0,06% | Ações |
| Aquatic Capital Management LLC | $335.300 | 78.709 | 0,06% | Ações |
| Rockefeller Capital Management L.P. | $332.996 | 78.168 | 0,06% | Ações |
| Vanguard Investments Australia, Ltd. | $314.929 | 73.927 | 0,06% | Ações |
| JANUS HENDERSON GROUP PLC | $313.658 | 127.763 | 0,06% | Ações |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $312.203 | 73.287 | 0,06% | Ações |
| Sequoia Financial Advisors, LLC | $296.935 | 69.703 | 0,05% | Ações |
| INTECH INVESTMENT MANAGEMENT LLC | $284.653 | 66.820 | 0,05% | Ações |
| COMMONWEALTH EQUITY SERVICES, LLC | $280.421 | 65.827 | 0,05% | Ações |
| China Universal Asset Management Co., Ltd. | $262.714 | 61.670 | 0,05% | Ações |
| LPL Financial LLC | $260.060 | 61.047 | 0,05% | Ações |
| SIMPLEX TRADING, LLC | $258.790 | 60.749 | 0,05% | Ações |
| Cetera Investment Advisers | $241.546 | 56.701 | 0,04% | Ações |
| Painted Porch Advisors LLC | $227.620 | 53.432 | 0,04% | Ações |
Executivos da empresa 43 insiders · 27 diretores · 18 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Michael Castagna | Chief Executive Officer | 15 de Julho de 2026 M | 2.433.779 | 1 | 4 | $-990.292 |
| Hakan Edstrom | President & CEO | 27 de Agosto de 2015 A | 1.114.340 | 0 | 0 | $0 |
| Christopher B Prentiss | Chief Financial Officer | 15 de Julho de 2026 F | 318.668 | 0 | 0 | $0 |
| Juergen Martens | Corporate VP and COO | 27 de Agosto de 2015 A | 106.539 | 0 | 0 | $0 |
| Dominic Marasco | Pres, Endocrine Business Unit | 15 de Julho de 2026 F | 343.398 | 0 | 0 | $0 |
| Sanjay R Singh | EVP Technical Operations | 15 de Julho de 2026 M | 478.966 | 0 | 1 | $-94.448 |
| Stuart A Tross | Chief People & Workpl Officer | 15 de Julho de 2026 M | 1.058.142 | 0 | 2 | $-548.528 |
| David Thomson | EVP Genl Counsel & Secretary | 15 de Julho de 2026 M | 797.554 | 0 | 3 | $-930.755 |
| Ajay Ahuja | Chief Medical Officer | 23 de Março de 2026 A | 318.200 | 0 | 0 | $0 |
| Lauren M Sabella | EVP Operations | 15 de Julho de 2025 F | 349.841 | 0 | 0 | $0 |
| Burkhard Blank | EVP Chief Medical Officer | 15 de Julho de 2025 F | 460.791 | 0 | 0 | $0 |
| Joseph Kocinsky | Chief Technology Officer | 27 de Agosto de 2022 F | 745.233 | 0 | 0 | $0 |
| Alejandro Galindo | EVP Endocrine Business Unit | 28 de Fevereiro de 2022 A | 576.690 | 0 | 0 | $0 |
| Rosabel Realica Alinaya | VP, IR & Treasury | 27 de Agosto de 2020 A | 167.119 | 0 | 0 | $0 |
| David M Kendall | Chief Medical Officer | 31 de Julho de 2020 P | 41.059 | 0 | 0 | $0 |
| Patrick Mccauley | Chief Commercial Officer | 25 de Fevereiro de 2020 A | 83.972 | 0 | 0 | $0 |
| Courtney Barton | Chief Compl & Privacy Officer | 31 de Julho de 2019 P | 29.584 | 0 | 0 | $0 |
| Elizabeth Garrett Ingram | Chief Marketing Officer | 14 de Maio de 2019 A | 43.012 | 0 | 0 | $0 |
| Raymond W. Urbanski | Corp VP, CMO | 10 de Agosto de 2017 S | 2.924 | 0 | 0 | $0 |
| Linda A Adreveno | Sr. VP, HR | 18 de Fevereiro de 2016 A | 92.200 | 0 | 0 | $0 |
| Alfred E Mann | Executive Chairman | 22 de Agosto de 2015 F | 1.005.990 | 0 | 0 | $0 |
| Diane Palumbo | Vice President, Human Resource | 23 de Fevereiro de 2015 F | 50.624 | 0 | 0 | $0 |
| Peter C Richardson | Chief Scientific Officer | 3 de Março de 2012 F | 133.611 | 0 | 0 | $0 |
| Richard L Anderson | Corporate VP | 16 de Novembro de 2008 F | 204.401 | 0 | 0 | $0 |
| John R. Riesenberger | VP & Chief Commercial Officer | 13 de Agosto de 2008 A | 14.650 | 0 | 0 | $0 |
| Dan Burns | VP & President, MKBP | 8 de Dezembro de 2006 A | 14.800 | 0 | 0 | $0 |
| Wendell W Cheatham | VP, Medical & Reg Affairs | 19 de Agosto de 2004 A | 300 | 0 | 0 | $0 |
| Sabrina Kay | Conselheiro | 20 de Maio de 2026 A | 265.600 | 0 | 0 | $0 |
| Jennifer Grancio | Conselheiro | 20 de Maio de 2026 A | 244.815 | 0 | 0 | $0 |
| James Samuel Shannon | Conselheiro | 20 de Maio de 2026 A | 64.635 | 0 | 0 | $0 |
| Michael A Friedman | Conselheiro | 20 de Maio de 2026 A | 47.500 | 0 | 0 | $0 |
| Anthony C Hooper | Conselheiro | 20 de Maio de 2026 A | 236.153 | 0 | 0 | $0 |
| Christine Mundkur | Conselheiro | 20 de Maio de 2026 A | 254.493 | 0 | 0 | $0 |
| Ronald J Consiglio | Conselheiro | 20 de Maio de 2026 A | 132.342 | 0 | 0 | $0 |
| Kent Kresa | Conselheiro | 15 de Maio de 2024 A | 274.541 | 0 | 0 | $0 |
| Henry L Nordhoff | Conselheiro | 14 de Maio de 2019 A | 103.426 | 0 | 0 | $0 |
| David Maccallum | Conselheiro | 16 de Maio de 2018 A | 114.790 | 0 | 0 | $0 |
| Matthew J Pfeffer | Conselheiro | 28 de Agosto de 2017 F | 81.961 | 0 | 0 | $0 |
| Abraham E Cohen | Conselheiro | 17 de Agosto de 2012 S | 56.424 | 0 | 0 | $0 |
| Heather Hay Murren | Conselheiro | 13 de Agosto de 2008 A | 10.100 | 0 | 0 | $0 |
| Kathleen Connell | Conselheiro | 25 de Maio de 2006 A | — | 0 | 0 | $0 |
| Llew Keltner | Conselheiro | 25 de Maio de 2006 A | — | 0 | 0 | $0 |
| Steven B. Binder | — | 7 de Agosto de 2026 S | 785.867 | 0 | 3 | $-427.369 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Alfred E. Mann, Alfred E. Mann Living Trust, Biomed Partners, LLC, Minimed Infusion, Inc., The Mann Group LLC ×2 declarações | 10 de Julho de 2012 | — | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada, Pessoa de relato não divulgada | 31 de Janeiro de 2006 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 41 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| RNIN · EA Series Trust | 1,43% | 773.251 NS | 30 de Abril de 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 0,74% | 317.578 NS | 31 de Maio de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 29.662 SH | 8 de Agosto de 2026 | Diário |
| AGNG · Global X Funds | 0,46% | 98.947 NS | 31 de Maio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,34% | 625.921 NS | 30 de Abril de 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,11% | 64.525 NS | 31 de Maio de 2026 | N-PORT |
| IBB · iShares Trust | 0,09% | 2.170.137 SH | 8 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,09% | 16.814 SH | 8 de Agosto de 2026 | Diário |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 330.117 SH | 8 de Agosto de 2026 | Diário |
| IWO · iShares Trust | 0,07% | 2.772.931 SH | 8 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,06% | 449.515 SH | 8 de Agosto de 2026 | Diário |
| BIB · ProShares Trust | 0,06% | 11.389 NS | 31 de Maio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,04% | 114.273 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 1.771.496 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,04% | 7.830.029 SH | 8 de Agosto de 2026 | Diário |
| ISCG · iShares Trust | 0,04% | 94.032 SH | 8 de Agosto de 2026 | Diário |
| ITWO · ProShares Trust | 0,03% | 14.400 NS | 31 de Maio de 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 132.607 NS | 30 de Abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 1.466.402 NS | 31 de Maio de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 61.465 NS | 31 de Maio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 874.372 SH | 8 de Agosto de 2026 | Diário |
| ISCB · iShares Trust | 0,02% | 13.557 SH | 8 de Agosto de 2026 | Diário |
| UWM · ProShares Trust | 0,02% | 11.261 NS | 31 de Maio de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 135.688 NS | 30 de Abril de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 638.128 NS | 30 de Abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 11.390 NS | 31 de Maio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3.543.398 SH | 8 de Agosto de 2026 | Diário |
| WSML · iShares Trust | 0,01% | 16.464 SH | 8 de Agosto de 2026 | Diário |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 12.000 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 286 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 452.118 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 27.701 NS | 30 de Abril de 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 1.330 NS | 31 de Maio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 465.445 SH | 8 de Agosto de 2026 | Diário |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 196.006 NS | 31 de Maio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 83.220 SH | 8 de Agosto de 2026 | Diário |
| TILT · FlexShares Trust | 0,00% | 10.345 NS | 30 de Abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 32.093 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 14.557 NS | 30 de Abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.327.332 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 26.184 SH | 8 de Agosto de 2026 | Diário |